BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29133763)

  • 1. Effects of Melatonin Levels on Neurotoxicity of the Medial Prefrontal Cortex in a Rat Model of Parkinson's Disease.
    Li Y; Wang SM; Guo L; Zhu J; Wang Y; Li L; Zhao YX
    Chin Med J (Engl); 2017 Nov; 130(22):2726-2731. PubMed ID: 29133763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Pinealectomy and Gonadectomy on Olfactory Bulb Dopaminergic Neurons in Rats.
    Li Y; Zhu J; Wang Y; Guo L; Li L; Wang D
    Chin Med J (Engl); 2017 Oct; 130(19):2302-2306. PubMed ID: 28937035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model.
    Ozsoy O; Yildirim FB; Ogut E; Kaya Y; Tanriover G; Parlak H; Agar A; Aslan M
    Free Radic Res; 2015; 49(8):1004-14. PubMed ID: 25791066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].
    Zheng L; Wang H; Ba YY; Liu HL; Wang M; Guo WW; Wu X; Yang H
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1660-5. PubMed ID: 25095380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the beneficial effect of melatonin in experimental Parkinson's disease.
    Yildirim FB; Ozsoy O; Tanriover G; Kaya Y; Ogut E; Gemici B; Dilmac S; Ozkan A; Agar A; Aslan M
    Neurochem Int; 2014 Dec; 79():1-11. PubMed ID: 25263280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of neurotoxin damage of 6-OHDA to dopaminergic nigral neuron by subthalamic nucleus lesions.
    Chen L; Liu Z; Tian Z; Wang Y; Li S
    Stereotact Funct Neurosurg; 2000; 75(2-3):66-75. PubMed ID: 11740172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesocortical Dopamine Phenotypes in Mice Lacking the Sonic Hedgehog Receptor Cdon.
    Verwey M; Grant A; Meti N; Adye-White L; Torres-Berrío A; Rioux V; Lévesque M; Charron F; Flores C
    eNeuro; 2016; 3(3):. PubMed ID: 27419218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific effects of 6-hydroxydopamine lesions of the rat medial prefrontal cortex on stress-induced c-fos expression in subcortical areas.
    Sui ZY; Li CR; Huang GB; Kwon YB; Kim KW; Lee KH; Chung YC
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1054-9. PubMed ID: 20677375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats.
    Chen L; Liu J; Zhang QJ; Feng JJ; Gui ZH; Ali U; Wang Y; Fan LL; Hou C; Wang T
    Brain Res Bull; 2011 Jul; 85(6):329-38. PubMed ID: 21624440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
    Ramírez-García G; Palafox-Sánchez V; Limón ID
    Neuroscience; 2015 Apr; 290():492-508. PubMed ID: 25644418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
    Li J; Wang LN; Xiao HL; Li X; Yang JJ
    Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease.
    Schlachetzki JC; Marxreiter F; Regensburger M; Kulinich A; Winner B; Winkler J
    Restor Neurol Neurosci; 2014; 32(4):447-62. PubMed ID: 24604006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin prevents formaldehyde-induced neurotoxicity in prefrontal cortex of rats: an immunohistochemical and biochemical study.
    Zararsiz I; Kus I; Ogeturk M; Akpolat N; Kose E; Meydan S; Sarsilmaz M
    Cell Biochem Funct; 2007; 25(4):413-8. PubMed ID: 16397905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools.
    Gomide V; Bibancos T; Chadi G
    Int J Neurosci; 2005 Apr; 115(4):557-82. PubMed ID: 15804725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of electroacupuncture on morphological changes and apoptosis of substantia nigra cells in Parkinson's disease rats].
    Wang YC; Cheng YH; Ma J; Gan SY; Wang SJ; Zhou H; Du YJ; Yang M; Shen F
    Zhen Ci Yan Jiu; 2010 Dec; 35(6):415-21. PubMed ID: 21375014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat.
    Zhang QJ; Wang S; Liu J; Ali U; Gui ZH; Wu ZH; Hui YP; Wang Y; Chen L
    Brain Res; 2010 Feb; 1312():127-37. PubMed ID: 19948151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-HT1A receptor antagonist WAY-100635 inhibits neuronal activity of the ventromedial prefrontal cortex in a rodent model of Parkinson's disease.
    Cao J; Liu J; Zhang QJ; Wang T; Wang S; Han LN; Li Q
    Neurosci Bull; 2007 Nov; 23(6):315-22. PubMed ID: 18064060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson's disease in rats.
    Pan X; Chen C; Huang J; Wei H; Fan Q
    Neurosci Lett; 2015 Jul; 600():220-5. PubMed ID: 26101828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment.
    Haddadi R; Eyvari-Brooshghalan S; Nayebi AM; Sabahi M; Ahmadi SA
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2427-2437. PubMed ID: 32715318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.